U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526454) titled 'Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder' on April 06.
Brief Summary: This study aimed to compare the efficacy, safety, and tolerability of electroconvulsive therapy (ECT) versus intravenous (IV) ketamine in adults with treatment-resistant major depressive disorder (TRD).
Study Start Date: July 01, 2025
Study Type: INTERVENTIONAL
Condition:
Electroconvulsive Therapy
Intravenous Ketamine
Treatment-Resistant
Major Depressive Disorder
Intervention:
DRUG: Electroconvulsive Therapy
Patients received Bitemporal electroconvulsive Therapy (ECT) (2x/week for 4 weeks).
DRU...